Chemomab’s PSC Trial Shows Positive Liver Biomarker Results
Chemomab Therapeutics announced positive 48-week data from the open-label extension (OLE) of its Phase 2 SPRING trial for nebokitug...
Azitra: Revolutionizing Skin Disease Treatment
In this interview, Francisco Salva, CEO of Azitra, shared insights into the company’s innovative approach to treating skin diseases....
Candel Therapeutics Reports Prolonged Overall Survival in Phase 2a Trial of CAN-2409 in Advanced NSCLC
Candel Therapeutics announced final survival data from a Phase 2a clinical trial of CAN-2409 in patients with advanced non-small...
Rani Therapeutics Announces Bioequivalence of Oral GLP-1/GLP-2 Dual Agonist RT-114
Rani Therapeutics announced positive preclinical data for RT-114, an oral formulation of ProGen’s GLP-1/GLP-2 dual agonist, PG-102, for obesity...
Nephrologists Embrace Aggressive IgA Nephropathy Treatment
Spherix’s recent study of 507 IgA nephropathy (IgAN) patients reveals a disconnect between treatment goals and real-world disease management,...
Sonnet Biotherapeutics’ SON-1010 Shows Promising Safety in Sarcoma Combination Trial
Sonnet BioTherapeutics announced positive safety data from an expansion cohort of its Phase 1 SB101 trial. The trial is...
Decoy Therapeutics’ Novel Inhibitors Show Promise Against Measles
Decoy Therapeutics, a preclinical biopharmaceutical company, has announced that its antiviral drug candidates, designed using its IMP3ACT™ platform, have...
Acu193 Alzheimer’s Trial Enrollment Complete
Acumen Pharmaceuticals has completed enrollment in its Phase 2 ALTITUDE-AD trial of sabirnetug (ACU193) for early-stage Alzheimer’s diseaseAlzheimer’s disease....
City of Hope & Calidi Biotherapeutics Phase 1 Trial Update on CLD-101
Calidi Biotherapeutics and City of Hope announced positive progress in a Phase 1 clinical trial for CLD-101, a neural...
Pleco PTX-252 Shows Promise in AML FDA Meeting
Pleco Therapeutics, a clinical-stage biopharmaceutical company, has received positive feedback from the FDA regarding its Investigational New Drug (IND)...